ORGO vs WY · rev $81.0M vs P/E 43, rev $3.59B
Organogenesis Holdings Inc (ORGO) versus Weyerhaeuser Company (WY) — a side-by-side from cached financials, not a winner call.
Organogenesis Holdings Inc (ORGO) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Weyerhaeuser Company (WY) is a reit - specialty company listed on NYSE.
Latest reported ORGO revenue for 2026-06-30 was $81.0M. Net income was -$149.4M. ORGO currently screens at market cap $301.1M.
Latest reported WY revenue for 2026-06-30 was $3.59B. Net income was $318.0M. WY currently screens at market cap $17.54B and trailing P/E 43.4.
ORGO currently screens at market cap $301.1M. WY currently screens at market cap $17.54B and trailing P/E 43.4.
Not investment advice. Open the ORGO and WY stock pages for the full models.
Not investment advice.